With $16 million gift, Columbia will open a new center for Lyme and other tick-borne diseases this summer, offering patients specialized care and expanding research at a national level.
A collaboration between Observational Health Data Sciences and Informatics (OHDSI) and Health Level Seven International (HL7) will improve access and sharing of health care data among researchers.
A clinical trial to test a gene therapy for some patients with dry age-related macular degeneration—a leading cause of blindness in the United States—is underway at Columbia and NewYork-Presbyterian.
Spread of a new SARS-CoV-2 variant in the New York City region that shares worrisome similarities with other recent variants has been identified by scientists at Columbia University.
Scientists at Columbia have developed a gene-editing tool—using jumping genes—that inserts any DNA sequence into the genome without cutting, fixing a major shortcoming of existing CRISPR technology.
A new study suggests that providers make the same number of wrong-patient errors regardless of the number of electronic patient records they could have open at a time.
Columbia engineers and surgeons show that new salvage methods can recondition severely damaged lungs to meet transplantation criteria and could make more lungs available for patients.
A new study suggests that depression and GI trouble sometimes spring from the same source—low serotonin—and identifies a potential treatment that could ease both conditions.
Four researchers at VP&S have been named 2019 Schaefer Research Scholars and will pursue new ideas in cancer metastasis, neurodegenerative disease, and compulsive behavior.
A new study from Columbia pediatricians found that new mothers are more receptive to educational materials that contain facts, not criticism, about sugary drinks.
Columbia researchers may have uncovered a new way to prevent, and possibly reverse, the liver's deterioration during fatty liver disease, which affects one in four Americans.